These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20030577)

  • 41. [Non-invasive detection of liver fibrosis in patients with chronic hepatitis C].
    Aiglová K; Ehrmann J; Ehrmann J
    Cas Lek Cesk; 2007; 146(6):542-5. PubMed ID: 17650594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
    Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
    Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease.
    Gómez-Domínguez E; Mendoza J; Rubio S; Moreno-Monteagudo JA; García-Buey L; Moreno-Otero R
    Aliment Pharmacol Ther; 2006 Aug; 24(3):513-8. PubMed ID: 16886917
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C. Results from a cohort of 324 patients.
    Lupşor M; Badea R; Stefănescu H; Grigorescu M; Sparchez Z; Serban A; Branda H; Iancu S; Maniu A
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):155-63. PubMed ID: 18568136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
    Sebastiani G; Halfon P; Castera L; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
    Aliment Pharmacol Ther; 2012 Jan; 35(1):92-104. PubMed ID: 22035045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
    Islam S; Antonsson L; Westin J; Lagging M
    Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation.
    Viganò M; Paggi S; Lampertico P; Fraquelli M; Massironi S; Ronchi G; Rigamonti C; Conte D; Colombo M
    Aliment Pharmacol Ther; 2011 Aug; 34(3):353-62. PubMed ID: 21631559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy.
    Calvaruso V; Cammà C; Di Marco V; Maimone S; Bronte F; Enea M; Dardanoni V; Manousou P; Pleguezuelo M; Xirouchakis E; Attanasio M; Dusheiko G; Burroughs AK; Craxì A
    J Viral Hepat; 2010 Jul; 17(7):469-74. PubMed ID: 19780940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.
    Rizzo L; Calvaruso V; Cacopardo B; Alessi N; Attanasio M; Petta S; Fatuzzo F; Montineri A; Mazzola A; L'abbate L; Nunnari G; Bronte F; Di Marco V; Craxì A; Cammà C
    Am J Gastroenterol; 2011 Dec; 106(12):2112-20. PubMed ID: 21971536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
    Tu XL; Xiao YQ; Chen F
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
    Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An inexpensive and worldwide available digital image analysis technique for histological fibrosis quantification in chronic hepatitis C.
    Campos CF; Paiva DD; Perazzo H; Moreira PS; Areco LF; Terra C; Perez R; Figueiredo FA
    J Viral Hepat; 2014 Mar; 21(3):216-22. PubMed ID: 24438683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rate of natural disease progression in patients with chronic hepatitis C.
    Zarski JP; Mc Hutchison J; Bronowicki JP; Sturm N; Garcia-Kennedy R; Hodaj E; Truta B; Wright T; Gish R
    J Hepatol; 2003 Mar; 38(3):307-14. PubMed ID: 12586296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Important issues in determining the cut-offs for liver fibrosis index.
    Sertoglu E; Kayadibi H; Uyanik M
    J Clin Gastroenterol; 2015 Jan; 49(1):90-1. PubMed ID: 25485515
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of fibrosis and hepatitis C.
    Friedman SL
    Am J Med; 1999 Dec; 107(6B):27S-30S. PubMed ID: 10653452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.